Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Transplant. 2017 Nov 1;18(4):843–854. doi: 10.1111/ajt.14523

Figure 4. CD47mAb treatment decreased the inflammatory response of the DCD renal grafts.

Figure 4

(A) CD3+ T lymphocytes were visualized by immunofluorescence staining in renal tissue at 48 hours after transplantation (magnification ×400). (B) The number of infiltrating CD3+ cells were quantified and found to be significantly decreased in the CD47mAb treated renal grafts versus the control group in both the syngeneic and allogeneic models.